Havnoz Biomoluxe Private Limited
Havnoz Biomoluxe Private Limited is a biotechnology company specializing in engineered peptide biomolecules and advanced computational drug discovery. They leverage peptide engineering, AI-assisted synthetic biology, and quantum computing to develop novel bioactive peptides and optimize drug candidates. Their Quantum Simulation Platform as a Service (QSPaaS) accelerates early-stage drug discovery by simulating molecular interactions with quantum algorithms, integrated with AI and machine learning for precision medicine. The company offers contract research services in strain engineering and drug development, utilizing computational and systems biology platforms to optimize microbial strains and streamline therapeutic discovery. Havnoz Biomoluxe is recognized for innovation with awards such as the Startup Grant 2024 by CUSAT-TBI, positioning them as a cutting-edge player in biotech and pharmaceutical R&D.
Havnoz Biomoluxe Private Limited
Havnoz Biomoluxe Private Limited is a biotechnology company specializing in engineered peptide biomolecules and advanced computational drug discovery. They leverage peptide engineering, AI-assisted synthetic biology, and quantum computing to develop novel bioactive peptides and optimize drug candidates. Their Quantum Simulation Platform as a Service (QSPaaS) accelerates early-stage drug discovery by simulating molecular interactions with quantum algorithms, integrated with AI and machine learning for precision medicine. The company offers contract research services in strain engineering and drug development, utilizing computational and systems biology platforms to optimize microbial strains and streamline therapeutic discovery. Havnoz Biomoluxe is recognized for innovation with awards such as the Startup Grant 2024 by CUSAT-TBI, positioning them as a cutting-edge player in biotech and pharmaceutical R&D.